title: New rhinophyma severity index and mid-term results following shave excision of rhinophyma.
abstract: BACKGROUND
  Rhinophyma is a progressive nasal deformity resulting from hyperplasia of the sebaceous glands and connective tissue, with a negative effect on quality of life. Partial-thickness shave excision has been used for the treatment of rhinophyma, but the mid- and long-term efficacy of the treatment is unknown.
  
  
  OBJECTIVE
  We analysed the clinical outcomes of shave excision in patients with rhinophyma in our centre between 2005 and 2009.
  
  
  METHODS
  The entire nose was shaved using a scalpel while under tumescent anaesthesia. The clinical assessment was scored using a novel Rhinophyma Severity Index.
  
  
  RESULTS
  Thirty-three patients with rhinophyma and shave excision were recruited for the study. A mid-term follow-up examination was possible in 23/33 (69.7%) patients. After a mean follow-up of 37.4 ± 13.2 months, 21 (91.3%) patients showed an improved Rhinophyma Severity Index (3.3 ± 1.1 to 1.7 ± 0.9, p < 0.0001). All patients reported a high level of satisfaction after surgery (excellent or good result). Eleven (47.8%) patients developed rhinophyma recurrence.
  
  
  CONCLUSIONS
  Shave excision under tumescent anaesthesia is an effective treatment for rhinophyma. The treatment is associated with high patient satisfaction and minimal side effects. A possible recurrence of rhinophyma must be addressed, however, while obtaining informed consent.
authors.affiliation: Department of Dermatology, Venereology and Allergology, University of Leipzig Medical Centre, Leipzig, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Wetzig
authors.forename: M
authors.initials: M
authors.lastname: Averbeck
authors.forename: J C
authors.initials: JC
authors.lastname: Simon
authors.forename: M
authors.initials: M
authors.lastname: Kendler
mesh_terms: D000368:Aged; D000577:Amides; D000772:Anesthesia, Local / Q000379:methods; D000779:Anesthetics, Local; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008012:Lidocaine; D008297:Male; D008875:Middle Aged; D017060:Patient Satisfaction; D019106:Postoperative Hemorrhage / Q000209:etiology; D012008:Recurrence; D012189:Retrospective Studies; D012224:Rhinophyma / Q000601:surgery*; D000077212:Ropivacaine; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000577:Amides; D000779:Anesthetics, Local; D000077212:Ropivacaine; D008012:Lidocaine